FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048569348> ?p ?o ?g. }

• W3048569348 endingPage "1991" @default.
• W3048569348 startingPage "1981" @default.
• W3048569348 abstract "Abstract TAS-119 is a novel orally active, selective inhibitor of Aurora kinase A identified as a clinical candidate for efficacy testing in combination with taxanes. In vitro, TAS-119 enhanced cell growth inhibition of paclitaxel in multiple human cancer cell lines derived from various tissues, including paclitaxel-resistant cell lines. Interestingly, TAS-119 did not enhance paclitaxel antitumor activity in normal lung diploid fibroblast cell lines WI-38 and MRC5. In vivo, TAS-119 enhanced the antitumor efficacy of paclitaxel and docetaxel in multiple models at doses inhibitory to Aurora A in tumors. Moreover, the drug combination was well tolerated, and TAS-119 did not exaggerate clinically documented side effects of taxanes, neutropenia and neurotoxicity, in rats. The same TAS-119 concentration enhanced the cell growth inhibitory activity of three clinically approved taxanes, paclitaxel, docetaxel, and cabazitaxel. The degree of enhancement calculated as fold of change of the IC50 value for each taxane was almost the same among the three taxanes. We conducted in vitro and in vivo experiments to develop an optimized combination therapy regimen for TAS-119 with paclitaxel/docetaxel. Using in vitro and in vivo models, we tested the drug administration order for TAS-119 combined with paclitaxel and the TAS-119 treatment duration. The best regimen in preclinical models was combining paclitaxel or docetaxel treatment with 4 days of TAS-119 dosing, which was initiated on the same day as the paclitaxel or docetaxel administration or one day later. This information provided guidance for the design of a clinical trial of TAS-119 and paclitaxel or docetaxel combination." @default.
• W3048569348 created "2020-08-18" @default.
• W3048569348 creator A5002280001 @default.
• W3048569348 creator A5018851840 @default.
• W3048569348 creator A5022827164 @default.
• W3048569348 creator A5029873173 @default.
• W3048569348 creator A5034292501 @default.
• W3048569348 creator A5045036399 @default.
• W3048569348 date "2020-10-01" @default.
• W3048569348 modified "2023-09-30" @default.
• W3048569348 title "Aurora A Inhibitor TAS-119 Enhances Antitumor Efficacy of Taxanes <i>In Vitro</i> and <i>In Vivo</i>: Preclinical Studies as Guidance for Clinical Development and Trial Design" @default.
• W3048569348 cites W1902591710 @default.
• W3048569348 cites W1970815499 @default.
• W3048569348 cites W1981765582 @default.
• W3048569348 cites W1992446787 @default.
• W3048569348 cites W2005452896 @default.
• W3048569348 cites W2007978156 @default.
• W3048569348 cites W2050062343 @default.
• W3048569348 cites W2064261028 @default.
• W3048569348 cites W2064337685 @default.
• W3048569348 cites W2093549611 @default.
• W3048569348 cites W2101189408 @default.
• W3048569348 cites W2108929767 @default.
• W3048569348 cites W2115654148 @default.
• W3048569348 cites W2123244616 @default.
• W3048569348 cites W2125089526 @default.
• W3048569348 cites W2125294721 @default.
• W3048569348 cites W2128553601 @default.
• W3048569348 cites W2134667653 @default.
• W3048569348 cites W2134931983 @default.
• W3048569348 cites W2150548655 @default.
• W3048569348 cites W2166030259 @default.
• W3048569348 cites W2166198191 @default.
• W3048569348 cites W2278109184 @default.
• W3048569348 cites W2470602494 @default.
• W3048569348 cites W2749549060 @default.
• W3048569348 cites W2788536359 @default.
• W3048569348 cites W2792768542 @default.
• W3048569348 cites W2794945244 @default.
• W3048569348 cites W2799682570 @default.
• W3048569348 cites W2897708973 @default.
• W3048569348 cites W2914636049 @default.
• W3048569348 cites W2947719349 @default.
• W3048569348 cites W4240150408 @default.
• W3048569348 doi "https://doi.org/10.1158/1535-7163.mct-20-0036" @default.
• W3048569348 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32788206" @default.
• W3048569348 hasPublicationYear "2020" @default.
• W3048569348 type Work @default.
• W3048569348 sameAs 3048569348 @default.
• W3048569348 citedByCount "6" @default.
• W3048569348 countsByYear W30485693482021 @default.
• W3048569348 countsByYear W30485693482022 @default.
• W3048569348 countsByYear W30485693482023 @default.
• W3048569348 crossrefType "journal-article" @default.
• W3048569348 hasAuthorship W3048569348A5002280001 @default.
• W3048569348 hasAuthorship W3048569348A5018851840 @default.
• W3048569348 hasAuthorship W3048569348A5022827164 @default.
• W3048569348 hasAuthorship W3048569348A5029873173 @default.
• W3048569348 hasAuthorship W3048569348A5034292501 @default.
• W3048569348 hasAuthorship W3048569348A5045036399 @default.
• W3048569348 hasBestOaLocation W30485693482 @default.
• W3048569348 hasConcept C121608353 @default.
• W3048569348 hasConcept C126322002 @default.
• W3048569348 hasConcept C150903083 @default.
• W3048569348 hasConcept C207001950 @default.
• W3048569348 hasConcept C2776694085 @default.
• W3048569348 hasConcept C2777292972 @default.
• W3048569348 hasConcept C2777511904 @default.
• W3048569348 hasConcept C2777899217 @default.
• W3048569348 hasConcept C2778971682 @default.
• W3048569348 hasConcept C2780192828 @default.
• W3048569348 hasConcept C2781190966 @default.
• W3048569348 hasConcept C530470458 @default.
• W3048569348 hasConcept C71924100 @default.
• W3048569348 hasConcept C86803240 @default.
• W3048569348 hasConcept C98274493 @default.
• W3048569348 hasConceptScore W3048569348C121608353 @default.
• W3048569348 hasConceptScore W3048569348C126322002 @default.
• W3048569348 hasConceptScore W3048569348C150903083 @default.
• W3048569348 hasConceptScore W3048569348C207001950 @default.
• W3048569348 hasConceptScore W3048569348C2776694085 @default.
• W3048569348 hasConceptScore W3048569348C2777292972 @default.
• W3048569348 hasConceptScore W3048569348C2777511904 @default.
• W3048569348 hasConceptScore W3048569348C2777899217 @default.
• W3048569348 hasConceptScore W3048569348C2778971682 @default.
• W3048569348 hasConceptScore W3048569348C2780192828 @default.
• W3048569348 hasConceptScore W3048569348C2781190966 @default.
• W3048569348 hasConceptScore W3048569348C530470458 @default.
• W3048569348 hasConceptScore W3048569348C71924100 @default.
• W3048569348 hasConceptScore W3048569348C86803240 @default.
• W3048569348 hasConceptScore W3048569348C98274493 @default.
• W3048569348 hasFunder F4320311653 @default.
• W3048569348 hasFunder F4320337351 @default.
• W3048569348 hasIssue "10" @default.
• W3048569348 hasLocation W30485693481 @default.
• W3048569348 hasLocation W30485693482 @default.
• W3048569348 hasLocation W30485693483 @default.
• W3048569348 hasLocation W30485693484 @default.

• next